<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03752684</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-131212001</org_study_id>
    <nct_id>NCT03752684</nct_id>
  </id_info>
  <brief_title>Oxalobacter Formigenes Colonization and Urinary Oxalate Excretion</brief_title>
  <official_title>Oxalobacter Formigenes Colonization and Oxalate Excretion in Calcium Oxalate Kidney Stone Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to assess the efficacy of ingesting a small amount of
      the harmless bacterium Oxalobacter formigenes in establishing residence in the guts of human
      subjects and to determine whether this influences the oxalate passed in urine of healthy
      volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adults that are not colonized with O. formigenes, have no history of stone disease and are in
      good health as judged by their medical history, a complete metabolic profile of their serum,
      and ranges of ions that influence stone formation in two 24-hour urine collections, will be
      recruited from within the greater Birmingham area. Recruited subjects will be between the
      ages of 18 to 65 years and with a BMI &gt;19 and &lt;32.

      Subjects not colonized with O. formigenes will consume, firstly, a controlled diet containing
      50 mg oxalate and 1000mg calcium (low oxalate/normal calcium diet), followed by a 250 mg
      oxalate/400mg calcium controlled diet (moderately high oxalate/low calcium diet), with at
      least a one week washout between each diet, and then repeat the same sequence of diets after
      colonization with O.formigenes Group 1 strain OxCC13. Controlled diets will be prepared in
      the Metabolic Kitchen of the UAB Clinical Research Unit (CRU). Each subject will perform a
      sodium 13C2-oxalate oral load once at the end of each of the two dietary phases to assess
      dietary oxalate absorption. Sustainability of colonization will be determined over time. Loss
      of colonization will be confirmed by having the subject consume an oxalate-rich meal with
      subsequent testing for O. formigenes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Evaluate urinary oxalate excretion before and after colonization with the oxalate degrading bacterium Oxalobacter formigenes</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of urinary oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>1st 24 hour collection</time_frame>
    <description>1st 24 hour urine collection, started 24 hours after initiation of controlled diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of urinary oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>2nd 24 hour collection</time_frame>
    <description>48 hours post diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of urinary oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>3rd 24 hour collection</time_frame>
    <description>72 hours post diet</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of urinary oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>4th 24 hour urine collection</time_frame>
    <description>96 hours post diet</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of stool oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>Stool collected 48-96 hours post diet</time_frame>
    <description>First bowel movement collected during days 2 through 4 of dietary control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of stool oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>Stool collected 48-96 hours post diet</time_frame>
    <description>Second bowel movement collected during days 2 through 4 of dietary control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of stool oxalate by ion chromatography mass spectrometry</measure>
    <time_frame>Stool collected 48-96 hours post diet</time_frame>
    <description>Third bowel movement collected during days 2 through 4 of dietary control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of plasma oxalate by ion chromatography coupled with mass spectrometry</measure>
    <time_frame>Fasted plasma 4 days post diet</time_frame>
    <description>Fasted plasma oxalate after 4 days of controlled diet</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Calcium Oxalate Urolithiasis</condition>
  <arm_group>
    <arm_group_label>Low Oxalate Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects not colonized with Oxalobacter formigenes will be equilibrated to a low oxalate diet to determine baseline oxalate values in urine and plasma.
Subjects will be colonized with Oxalobacter formigenes (Intervention). Following colonization with Oxalobacter formigenes, urinary and plasma oxalate will be measured to determine the impact of colonization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderately high oxalate/low calcium diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects not colonized with Oxalobacter formigenes will be equilibrated to a moderately high oxalate/ low calcium oxalate diet to enhance dietary oxalate absorption.
Subjects will be colonized with Oxalobacter formigenes(Intervention). Following colonization with Oxalobacter formigenes, urinary and plasma oxalate will be measured to determine the impact of colonization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxalobacter formigenes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will ingest a liver preparation of O.formigenes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Oxalate Diet</intervention_name>
    <description>Subjects will be instructed to ingest a controlled diet low in oxalate</description>
    <arm_group_label>Low Oxalate Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderately high oxalate/low calcium diet</intervention_name>
    <description>Subjects will be instructed to ingest a controlled diet moderately high in oxalate</description>
    <arm_group_label>Moderately high oxalate/low calcium diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxalobacter formigenes</intervention_name>
    <description>Subjects will ingest liver preparation of O. formigenes</description>
    <arm_group_label>Oxalobacter formigenes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good health as judged from a medical history and reported medications

          -  Not colonized with O. formigenes

        Exclusion Criteria:

          -  History of any hepatic, renal, bowel or endocrine disease or any other condition that
             may influence the absorption, transport or urinary excretion of ions, which will
             compromise the interpretation of results

          -  colonized with O. formigenes

          -  abnormal urine chemistries or blood metabolic profiles
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Knight, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Knight, PhD</last_name>
    <phone>205-996-2295</phone>
    <email>johnknight@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Demond Wiley</last_name>
    <email>demondwiley@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Demond Wiley</last_name>
      <email>demondwiley@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>John Knight, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ross P Holmes, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dean G Assimos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert A Oster, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>November 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2018</study_first_posted>
  <last_update_submitted>February 28, 2020</last_update_submitted>
  <last_update_submitted_qc>February 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>John Knight</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Oxalobacter formigenes</keyword>
  <keyword>oxalate</keyword>
  <keyword>kidney stones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

